Related Experiment Video
Updated: Oct 13, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Effect of iron administration on the aortic iron content and vascular calcification in phosphorus-loaded chronic
Masa Nakanishi1, Ayako Goto1, Takahide Iwasaki2
1Division of Kidney, Dialysis and Cardiology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, 663-8501, Hyogo, Japan.
Insights
Iron administration in chronic kidney disease (CKD) increased aortic iron but did not worsen vascular calcification (VC). Nrf2 pathway activation correlated with iron levels, suggesting a role in oxidative stress response in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Cardiovascular disease (CVD) is a leading cause of death in chronic kidney disease (CKD) patients, potentially linked to oxidative stress.
- Vascular calcification (VC) is a key risk factor for accelerated CVD in CKD.
- Phosphorus (Pi), iron (Fe), and Nrf2 are critical modulators of VC and oxidative stress in CKD.
Purpose of the Study:
- To investigate the impact of iron (Fe) administration on aortic iron overload and vascular calcification (VC) in a rat model of CKD.
- To determine the involvement of Nrf2 and its related genes (ferritin H, HIF-1α) in the development of VC following Fe administration.
Main Methods:
- A CKD rat model was established using adenine and a high-Pi diet.
- CKD rats received oral or intraperitoneal Fe administration.
- Aortic Fe, calcium (Ca), and Pi content, along with Nrf2, ferritin H, HIF-1α, HMOX1, and NQO1 mRNA levels, were analyzed.
Main Results:
- Intraperitoneal Fe administration significantly increased aortic Fe content, correlating with liver hepcidin (HAMP) mRNA levels.
- Fe administration did not significantly alter aortic calcium (Ca) or phosphorus (Pi) content.
- Aortic Nrf2 mRNA levels increased with Fe administration, correlating with aortic Fe, serum Pi, and mRNA levels of ferritin H, HIF-1α, HMOX1, and NQO1.
Conclusions:
- Parenteral Fe administration elevates aortic Fe and liver HAMP mRNA but does not exacerbate VC in CKD rats.
- Aortic Nrf2 mRNA levels are significantly correlated with aortic Fe and serum Pi, indicating a role in the oxidative stress response.
- The Nrf2 pathway, along with ferritin H and HIF-1α, appears involved in the response to Fe loading and oxidative stress in CKD.
Background:
Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD) and could be related to oxidative stress. Vascular calcification (VC) has been established as a critical risk factor for accelerated CVD. In CKD, phosphorus (Pi), iron (Fe) and Nrf2 are modulators of VC and important agonists and antagonists of oxidative stress. The aim of this study was to determine whether Fe administration, which is commonly used to treat renal anemia, affects aortic Fe overload and VC, and whether Nrf2 and its related genes, ferritin H and HIF-1α, are involved in the development of VC.
Methods:
A CKD model was created in rats by administering adenine and simultaneously feeding a high-Pi diet. In addition to control and CKD rats without Fe administration (No-Fe group), Fe was administered orally (PO-Fe group) or intraperitoneally (IP-Fe group) to CKD animals to clarify the effects of Fe administration on the aortic Fe and calcium (Ca) contents and the involvement of Nrf2 and its induced antioxidative proteins, ferritin H and HIF-1α, in VC.
Results:
The aortic Fe content increased significantly in the IP-Fe group, which was closely correlated with liver HAMP (hepcidin) expression in all animals. Fe administration had no significant effect on the aortic Ca and Pi contents regardless of the route of Fe administration. The aortic mRNA level of Nrf2 was significantly increased in the IP-Fe group and correlated with serum Pi levels and aortic Fe contents, which could respond to oxidative stress. Notably, the mRNA level of Nrf2 was also significantly correlated with the mRNA levels of ferritin H and HIF-1α. Since we could not measure Nrf2 protein levels in this study, we confirmed the upregulation of HMOX1 and NQO1 mRNA expression in parallel with Nrf2 mRNA.
Conclusion:
Parenteral Fe administration increased aortic Fe in parallel with the liver HAMP mRNA level but did not affect VC. Aortic Nrf2 mRNA levels correlated significantly with aortic Fe and serum Pi levels and with aortic mRNA levels of ferritin H and HIF-1α as well as HMOX1 and NQO1.
More Related Videos
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

